Safehouse, the nonprofit behind Philadelphia’s proposed supervised injection facility, is waiting on a federal judge to determine whether it’s legal to open the first medical site of its kind in the U ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...
Study participants who were at least 30 years old, injected heroin, or had been in prison were more likely than participants without these characteristics to choose pre-exposure prophylaxis (PrEP) for ...
AUSTIN (KXAN) — Advocates for HIV prevention are calling a newly approved injectable medication a major step in eliminating the spread of the virus. This summer, the FDA approved Gilead’s lenacapavir, ...
The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...
A clinical trial has found an injectable HIV treatment could be an effective prevention for the infection, NPR reported July 3. A clinical trial by drugmaker Gilead conducted a randomized study on ...
The World Health Organization is now recommending that countries include a newly approved HIV drug for prevention, lenacapavir, as a tool in their efforts to fight HIV infections, especially for ...
Jessica Haberer has been a consultant for Merck and the US Centers for Disease Control and Prevention. She has been an investigator in studies with drug donation from Gilead and Viiv. She has received ...
The study also shows that the new injection, is 89% more effective in women than Truvada, the daily pill previously available. "This is the first time the world has seen such significant HIV ...
(CNN) — A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. (CNN) — A drug currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback